SkyePharma buys equity stake in RPT Pharma

Guest Contributor
September 5, 2001

UK-based SkyePharma plc has acquired a 40.2% interest in RTP Pharma Inc for US$20 million and has participated in a $15-million equity infusion to fund ongoing operations. The involvement of SkyePharma will assist the Montreal-based firm in expanding its market position through strategic project collaboration and access to Skye’s expertise in controlled release and inhalation technologies. RTP is a leader in the formulation of water-insoluble drugs. It’s Insoluble Drug Delivery (IDD) IDD technology platform helps to overcome problems of insolubility by enhancing the uptake and safety of water-soluble drugs across a range of therapeutic classes. Also participating in the financing is Innovatech du Grand Montréal, which invested $1.7 million....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.